Increased Serum Concentrations of Soluble Receptor for Advanced Glycation Endproducts in Patients with Type 1 Diabetes
- 1 September 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (9), 1749-1750
- https://doi.org/10.1373/clinchem.2005.051961
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic MenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Advanced glycation endproducts—role in pathology of diabetic complicationsDiabetes Research and Clinical Practice, 2005
- Roles of the Receptor for Advanced Glycation Endproducts in Diabetes-Induced Vascular InjuryJournal of Pharmacological Sciences, 2005
- Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injuryBiochemical Journal, 2003
- Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.Ageing Research Reviews, 2002
- Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetesActa Diabetologica, 2000